Sponsors

Targeted proteomics analysis

Applied Biosystems and its partner MDS Analytical Technologies has announced the availability of a suite of integrated mass spectrometry-based solutions for quantitative proteomics. Designed for Applied Biosystems/MDS Analytical Technologies’ triple quadrupole and hybrid triple quadrupole/ linear ion trap mass spectrometry systems, these solutions include software packages and consumables that permit the more effective quantification of proteins in biomarker research or cell biology.

Thousands of proteins may be present in any specific laboratory sample; however, scientists often need to study subsets of those that are present at low levels and that change in disease states. Targeted mass spectrometry is emerging as a powerful tool for these quantitative assays, yet key challenges remain.

mTRAQ reagents are chemical labelling kits for use in targeted proteomics experiments using MRM analysis that can be used to create global internal standards to provide an internal reference for every protein, peptide and post-translational modification in a sample. Based on proprietary Applied Biosystems’ technology, mTRAQ reagents are designed to improve analytical reproducibility for quantitative experiments without the need for costly custom-prepared synthetic peptides.

www3.appliedbiosystems.com

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024